Researchers find new mechanism to turn on cancer-killing T cells
A new mechanism involved in the anti-cancer immune response has been identified and may have implications for targeting antigens.
Hans Schreiber receives inaugural Jonas Memorial Award for contributions to cellular immunotherapy
Hans Schreiber, MD, PhD, was recognized for his dedication and significant contributions to the promising field of cellular immunotherapy for cancer treatment.
Novel biomarker predicts how non-small cell lung cancer will progress after immunotherapy
Researchers identified a novel biomarker for predicting the progression of non-small cell lung cancer after immunotherapy.